Back

RKT

-1.27%
NEUTRAL

Reckitt Benckiser Reports Mixed 2024 Results with Improved Adjusted Profits and Margins

Why we think this is neutral

Reckitt Benckiser's 2024 results present a mixed picture. On the positive side, the company reported improved adjusted operating profit, rising 3.0% to £3,475m, and an increase in adjusted EPS of 7.9% to 349.0p. The adjusted operating profit margin also expanded by 140bps to 24.5%. However, these gains are tempered by declines in IFRS operating profit (-4.2%) and IFRS EPS (-11.1%). LFL net revenue growth was modest at 1.4%, with strong performance in Hygiene (+4.2%) offset by weakness in Nutrition (-7.3%). The increase in net debt and impairment charges for IFCN and Biofreeze are concerning, but the company's outlook for 2025 and medium-term guidance are encouraging. The balance of positive and negative factors, along with the "trading in line" statement, supports a neutral outlook.

Key Points

  • LFL net revenue growth of 1.4% to £14,169m
  • Adjusted operating profit up 3.0% to £3,475m
  • Adjusted EPS increased 7.9% to 349.0p
  • IFRS operating profit down 4.2% to £2,425m
  • IFRS EPS decreased 11.1% to 203.2p
  • Hygiene segment grew 4.2%, Health 2.1%, Nutrition declined 7.3%
  • Net debt increased to £7,914m, with net debt/Adjusted EBITDA ratio at 2.0x
  • Impairment charges of £838m for IFCN and Biofreeze
  • Targeting 3-4% LFL net revenue growth for Core Reckitt in 2025
  • Medium-term guidance of 4-5% LFL net revenue growth from 2026

Summary

The consumer goods giant reported mixed 2024 results, with improved adjusted profits and margins, but faced challenges in its Nutrition segment and increased net debt.

Reckitt Benckiser's 2024 results show a mixed performance with LFL net revenue growth of 1.4% to £14,169m. The company saw improved adjusted operating profit of £3,475m (+3.0%) and adjusted EPS growth of 7.9% to 349.0p. However, IFRS figures declined, with operating profit down 4.2% and EPS down 11.1%. The Hygiene segment performed well with 4.2% growth, while Nutrition faced challenges with a 7.3% decline. Net debt increased to £7,914m, with the net debt/Adjusted EBITDA ratio rising to 2.0x. The company faced impairment charges of £838m related to IFCN and Biofreeze. Looking ahead, Reckitt is targeting 3-4% LFL net revenue growth for Core Reckitt in 2025 and 4-5% growth from 2026. The company maintains a strong market position with 55% of Top CMUs in Health and Hygiene holding or gaining share.

Key Dates

May 29, 2025
Final dividend payment
May 8, 2025
Annual General Meeting
Q1 2025
Q1 Trading Update
ANNUAL RESULTS